This topic contains a solution. Click here to go to the answer

Author Question: A nation's market-risk premium rises if: a. The volatility (e.g., standard deviation) of expected ... (Read 79 times)

APUS57

  • Hero Member
  • *****
  • Posts: 571
A nation's market-risk premium rises if:
 a. The volatility (e.g., standard deviation) of expected inflation rises.
  b. The average expected inflation rate rises.
  c. Security maturities lengthen.
  d. All of the above.

Question 2

Assume that the central bank sells government securities in the open market. If the nation has highly mobile international capital markets and a fixed exchange rate system, what happens to real GDP and monetary base in the context of the Three-Sector-Model? State your answer after the macroeconomic system returns to complete equilibrium.
 a. Real GDP rises and monetary base rises.
  b. Real GDP rises and monetary base falls.
  c. Real GDP and monetary base fall.
  d. Real GDP and monetary base remain the same.
  e. There is not enough information to determine what happens to these two macroeconomic variables.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

b614102004

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

.A

Answer to Question 2

.D




APUS57

  • Member
  • Posts: 571
Reply 2 on: Jun 30, 2018
Gracias!


amandalm

  • Member
  • Posts: 306
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Carbamazepine can interfere with the results of home pregnancy tests. If you are taking carbamazepine, do not try to test for pregnancy at home.

Did you know?

The average human gut is home to perhaps 500 to 1,000 different species of bacteria.

Did you know?

Nearly all drugs pass into human breast milk. How often a drug is taken influences the amount of drug that will pass into the milk. Medications taken 30 to 60 minutes before breastfeeding are likely to be at peak blood levels when the baby is nursing.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library